Submitted by Anonymous (not verified) on 13 December 2024 - 12:03
Human medicines European public assessment report (EPAR): Bamlanivimab and etesevimab for COVID-19, Status: Withdrawn (during rolling review)
Source:
Human medicines European public assessment report (EPAR): Bamlanivimab and etesevimab for COVID-19, Status: Withdrawn (during rolling review)